ADD/ADHD News

Cannabis use disorder was associated with self-harm, all-cause mortality, unintentional overdose death and homicide among youth with mood disorders, according to a study published in JAMA Pediatrics.

Methylphenidate use during pregnancy was not linked to an increased risk for malformations overall in a nationwide registry-based study with information on both prenatal and postnatal diagnoses published in Journal of Clinical Psychiatry.

Children with congenital heart disease are significantly more likely to have anxiety, depression or ADHD, according to data from a Texas hospital.

Antipsychotic use has declined among young children, but clinicians continue to prescribe them off-label for conditions not approved by the FDA, researchers found.

Several psychopharmacological and psychotherapeutic interventions can help treat adult ADHD, according to a presenter at the NEI Max virtual conference.

Individuals who were recently diagnosed with a mental disorder were at increased risk for COVID-19 infection, especially African Americans and women, according to study results published in World Psychiatry.

Viloxazine extended-release did not appear associated with risk for cardiac arrhythmias or other electrocardiographic parameters, according to study results published in Journal of Clinical Psychiatry.

In this video from the Annual Meeting of the American Neurological Association, Justin C. McArthur, MBBS, MPH, discussed the Presidential Symposium, Leveraging Digital Technologies in Neurology, that featured six presentations.

Stimulant use is generally safe and effective for treating ADHD among young people, but clinicians should be aware of the potential for misuse, according to a presenter at the Psych Congress 2020 Virtual Experience conference.

Young adults with ADHD, particularly women, were at increased risk for depression, suicidal ideation and suicide attempts vs. those without ADHD, according to study results published in Journal of Clinical Psychiatry.